DANIEL J BOOSER to Recombinant Proteins
This is a "connection" page, showing publications DANIEL J BOOSER has written about Recombinant Proteins.
Connection Strength
0.016
-
Phase I trial of dose-dense docetaxel and doxorubicin with or without sargramostim in patients with metastatic breast cancer. Drugs R D. 2005; 6(5):299-305.
Score: 0.010
-
Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer. J Immunother Emphasis Tumor Immunol. 1995 Oct; 18(3):185-7.
Score: 0.005